[go: up one dir, main page]

AU2002251140A1 - Chemical derivatives and their use as anti-telomerase agent - Google Patents

Chemical derivatives and their use as anti-telomerase agent

Info

Publication number
AU2002251140A1
AU2002251140A1 AU2002251140A AU2002251140A AU2002251140A1 AU 2002251140 A1 AU2002251140 A1 AU 2002251140A1 AU 2002251140 A AU2002251140 A AU 2002251140A AU 2002251140 A AU2002251140 A AU 2002251140A AU 2002251140 A1 AU2002251140 A1 AU 2002251140A1
Authority
AU
Australia
Prior art keywords
chemical derivatives
telomerase agent
telomerase
agent
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002251140A
Other versions
AU2002251140B2 (en
Inventor
Thomas Caulfield
Gilles Doerflinger
Francois Hamy
Abdelazize Laoui
Patrick Mailliet
Jean-Louis Mergny
Jean-Francois Riou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0103916A external-priority patent/FR2822468B1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority claimed from PCT/FR2002/001005 external-priority patent/WO2002076975A1/en
Publication of AU2002251140A1 publication Critical patent/AU2002251140A1/en
Application granted granted Critical
Publication of AU2002251140B2 publication Critical patent/AU2002251140B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002251140A 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent Ceased AU2002251140B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0103916A FR2822468B1 (en) 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT
FR01/03916 2001-03-23
FR01/10370 2001-08-02
FR0110370 2001-08-02
PCT/FR2002/001005 WO2002076975A1 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent

Publications (2)

Publication Number Publication Date
AU2002251140A1 true AU2002251140A1 (en) 2003-03-27
AU2002251140B2 AU2002251140B2 (en) 2007-03-15

Family

ID=26212933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002251140A Ceased AU2002251140B2 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent

Country Status (11)

Country Link
EP (1) EP1373252A1 (en)
JP (1) JP2004524349A (en)
AR (1) AR034297A1 (en)
AU (1) AU2002251140B2 (en)
CA (1) CA2442012A1 (en)
CO (1) CO5380035A1 (en)
IL (2) IL158056A0 (en)
MX (1) MXPA03008269A (en)
MY (1) MY130957A (en)
PE (1) PE20020959A1 (en)
WO (1) WO2002076975A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401833A2 (en) 2001-05-28 2004-03-31 Aventis Pharma S.A. Chemical derivatives and the use thereof as an anti-elomerase agent
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
AU2002361846A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
WO2004001018A2 (en) * 2002-06-25 2003-12-31 The Center For Blood Research, Inc. Vacuolins
FR2850970B1 (en) * 2003-02-07 2006-07-07 Aventis Pharma Sa CHEMICAL DERIVATIVES BINDING VERY SPECIFIC TO G-QUADRUPLEX DNA STRUCTURES AND THEIR APPLICATION AS A SPECIFIC ANTICANCER AGENT
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1984660B (en) 2003-07-03 2010-12-15 美瑞德生物工程公司 4-Arylamino-quinazolines as caspase-specific activators and inducers of apoptosis
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
NZ563245A (en) * 2005-05-19 2011-04-29 Prometic Biosciences Inc Triazine compounds and compositions thereof for the treatment of cancers
US8138338B2 (en) * 2006-07-31 2012-03-20 Glaxosmithkline Llc Aurora kinase inhibitors from an encoded small molecule library
US8415340B2 (en) * 2007-07-25 2013-04-09 Bristol-Myers Squibb Company Triazine kinase inhibitors
FR2948686B1 (en) * 2009-07-30 2011-08-19 Biomerieux Sa NEW PEPTIDASE SUBSTRATES
WO2019181714A1 (en) * 2018-03-20 2019-09-26 国立大学法人広島大学 Compound which inhibits telomere-binding protein, and telomere-binding protein inhibitor containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
JPH1160573A (en) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd Triazine derivative and telomerase inhibitor
US6262053B1 (en) * 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
AU2179001A (en) * 1999-11-29 2001-06-12 Aventis Pharma S.A. Arylamine derivatives and their use as anti-telomerase agent
US7375222B2 (en) * 2002-02-05 2008-05-20 Astellas Pharma Inc. 2,4,6-Triamino-1,3,5-triazine derivative

Similar Documents

Publication Publication Date Title
AUPR879601A0 (en) Novel chemical compounds and their use
AUPR001000A0 (en) Novel chemical compounds and their use
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2002314252A1 (en) Chemical derivatives and the use thereof as an anti-telomerase agent
AUPR283801A0 (en) Chemical compounds and methods
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2002367186A1 (en) Urea derivatives
AU2002358700A1 (en) Urea derivatives as vr1- antagonists
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
AU2002356664A1 (en) Beta-amino-alpha-cyanoacrylates and their use as herbicides
AU2003249909A1 (en) Phenoxypropenylphenyl derivatives and their use as herbicides
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2002247715A1 (en) Rylene derivatives and their use as dyes
AU2002251140A1 (en) Chemical derivatives and their use as anti-telomerase agent
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AUPR879701A0 (en) Novel chemical compounds and their use
AU2002953095A0 (en) Novel chemical compounds and their use
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent
AU2001282268A1 (en) Phenantridine derivatives and their use as anti-telomerase agent
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002241049A1 (en) Chemical derivatives and the use thereof as an anti-elomerase agent